Clearance Summary
Allergan Botox Needle Electrode received FDA 510(k) clearance under submission number K173815, sponsored by Natus Manufacturing Limited. The device was reviewed via the Traditional premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2018-06-29.
- Submission: K173815
- Applicant / Sponsor: Natus Manufacturing Limited
- Clearance pathway: Traditional
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.1385
- Decision date: 2018-06-29
Classification & Regulation
This clearance is catalogued under FDA product code IKT and 21 CFR 890.1385, within the Physical Medicine review panel as a Class II device.